top of page



Develop a strategic outlook for an infectious disease (ID) area and define organizational framework

Service Areas
Therapeutic Areas

Other Therapeutic Areas

Client Type

Big Pharma

Client Problems

  • Create a disease area strategy to align global and company specific views for an ID area

  • Define commercialization challenges and unmet need in the ID area

  • Enhance PTS for the assets in the ID area

What We Did

  • Literature review to understand treatment flow and identified key insights and unmet needs

  • Prioritized the indications and identified key questions for development and commercialization.

  • Generate a TPP for all the assets in the ID area

Our Results And Insight

  • Patient flow and opportunity assessment for each indication

  • Determined market share for each indication and asset

  • Indication overview and Minimally Viable TPP for all indications

  • Disease area indication prioritization

See other case studies

Commercial Strategy case studies >

Other Therapeutic Areas case studies >

Service Areas Details

Commercial Strategy (TPP Development, Disease Area Strategy)

Therapeutic Areas Details

Other Therapeutic Areas (Infectious Disease)

Featured Consultants
bottom of page